0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research nsclc therapeutics asia pacific markets 2019 personalized therapies focus untapped.Your search for "" gave back 1530304 results.
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the EGFR-TKI For Advanced NSCLC market will undergo major...
Catalog:
Arsta
April 2023
Price: USD 3,490.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Colorectal Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,500.00
The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global RNA Interference Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
February 2024
Price: USD 4,480.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,000.00
